Alex Woodell - Publications

Affiliations: 
2010-2015 Neuroscience Medical University of South Carolina, Charleston, SC, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Rohrer B, Vazquez-Chona F, Woodell A, Buttler A, Jones B. Metabolic impacts of cigarette smoke on the retina of complement-compromised mice Molecular Immunology. 102: 204. DOI: 10.1016/J.Molimm.2018.06.192  0.577
2016 Woodell A, Jones BW, Williamson T, Schnabolk G, Tomlinson S, Atkinson C, Rohrer B. A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular Injury. Investigative Ophthalmology & Visual Science. 57: 1728-37. PMID 27064393 DOI: 10.1167/Iovs.15-18471  0.578
2014 Woodell A, Rohrer B. A mechanistic review of cigarette smoke and age-related macular degeneration. Advances in Experimental Medicine and Biology. 801: 301-7. PMID 24664711 DOI: 10.1007/978-1-4614-3209-8_38  0.703
2013 Woodell A, Coughlin B, Kunchithapautham K, Casey S, Williamson T, Ferrell WD, Atkinson C, Jones BW, Rohrer B. Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury. Plos One. 8: e67894. PMID 23825688 DOI: 10.1371/Journal.Pone.0067894  0.642
2013 Thurman JM, Kulik L, Orth H, Wong M, Renner B, Sargsyan SA, Mitchell LM, Hourcade DE, Hannan JP, Kovacs JM, Coughlin B, Woodell AS, Pickering MC, Rohrer B, Holers VM. Detection of complement activation using monoclonal antibodies against C3d. The Journal of Clinical Investigation. 123: 2218-30. PMID 23619360 DOI: 10.1172/Jci65861  0.554
2013 Rohrer B, Kulik L, Mitchell L, Hourcade D, Hannan J, Coughlin B, Woodell A, Pickering M, Holers V, Thurman J. Novel monoclonal antibodies to C3d for non-invasively monitoring the activity of complement in glomerular and retinal disease Molecular Immunology. 56: 264. DOI: 10.1016/J.Molimm.2013.05.073  0.567
2012 Thurman JM, Kulik L, Mitchell LM, Hourcade DE, Hannan JP, Coughlin B, Woodell AS, Pickering MC, Rohrer B, Holers M. Novel monoclonal antibodies to C3d that target and identify in living animals sites of complement activation Immunobiology. 217: 1191. DOI: 10.1016/J.Imbio.2012.08.179  0.555
Show low-probability matches.